melanotan for vitiligo ii before after Afamelanotide tested as a new treatment – Vitiligo Clinic Eruptive Dysplastic Nevi Following Melanotan
Description
Retrieved 14 May 2022, from A Phase III, randomized, double blind, placebo controlled, parallel group study, to evaluate the safety and efficacy of subcutaneous implants of afamelanotide (16 mg) in patients suffering from polymorphic light eruption (PLE)
Accurate research outcomes depend on exceptional compound integrity
29 November 2008
Key Features: Synergistic Fat Metabolism Support Combines CLA, L-Carnitine, and Green Tea Extract to promote efficient fat burning and energy utilization
